Lv3
260 积分 2024-03-10 加入
Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report
19小时前
待确认
Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature
19小时前
待确认
Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature review
19小时前
已完结
Pembrolizumab associated Stevens–Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma
19小时前
已完结
Nivolumab-induced Stevens-Johnson syndrome: Not only due to PD-1 inhibition
19小时前
已完结
Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction
19小时前
待确认
Toxic epidermal necrolysis post apalutamide with preceding tislelizumab administration in a patient with two cancers
19小时前
待确认
Two novel cases of delayed drug rash after immune checkpoint inhibitors and platin combination treatment
19小时前
求助中
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy
19小时前
已完结
Lichenoid dermatitis following PD-1 inhibitor-induced toxic epidermal necrolysis: a case report and literature review
8天前
已完结
皖公网安备34019202002308
